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Purpose: Infected aortic aneurysms are difficult to treat, and are associated with significant mortality. Hospital survival is
poor in patients with severe aortic infection, Salmonella species infection, Staphylococcus aureus infection, aneurysm
rupture, and suprarenal aneurysm location. We reviewed the clinical outcome in 46 patients with primary infected aortic
aneurysms and identified clinical variables associated with prognosis.
Methods: Data were collected by means of retrospective chart review. Univariate and multivariate logistic regression
models were used for risk factor analysis.
Results: Between August 1995 and March 2003, 48 patients with primary infected aortic aneurysms were treated at our
hospitals. Two patients with negative culture results were excluded. Of the remaining 46 patients, 35 patients had aortic
aneurysms infected with Salmonella species and 11 patients had aortic aneurysms infected with microorganisms other
than Salmonella species. There were 20 suprarenal infections and 26 infrarenal infections. Surgical debridement and in
situ graft replacement were performed in 35 patients, with an early mortality rate of 11%. The incidence of late prosthetic
graft infection was 10%. The 90-day mortality rate in patients operated on was 0% for elective operation and 36% for
nonelective operation (P  .006, Fisher exact test). Independent predictors of aneurysm-related death were advanced
age, non-Salmonella infection, and no operation.
Conclusion: With timely surgical intervention and prolonged antibiotic treatment, in situ graft replacement provides an
excellent outcome in patients with primary infected aortic aneurysms and elective operation. Mortality is still high in
patients undergoing urgent operation. Advanced age, non-Salmonella infection, and no operation are major determinants
of mortality. (J Vasc Surg 2004;40:30-5.)Despite the recent improvements in surgical techniques
and antibiotic therapy, severe aortic infection and subse-
quent infected aortic aneurysm remains a lethal disease.1-6
Early diagnosis, and surgical intervention plus prolonged
antibiotic therapy are essential for survival.1-6 Reported
hospital mortality rate ranges from 16% to 44%.1-11 Hospital
survival is poor in patients with severe aortic infection,3-6,12
Salmonella species infection,13-16 Staphylococcus aureus in-
fection,5 aneurysm rupture,1,5,13 and suprarenal aneurysm
location.5,11,15 However, an appropriate statistical analysis
of risk factors for death has not been possible because of the
small number of cases in previous studies.1-16 Infected
aortic aneurysm is common in Taiwan.17,18 The surgical
outcome was good in our previous report of 19 patients.18
In this study we reviewed the clinical outcomes of 46
patients with primary infected aortic aneurysms and identi-
fied independent clinical variables associated with poor
prognosis. The present study included data for additional
patients and those previously reported.18
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Patients. From August 1995 to March 2003, 48 pa-
tients were admitted to our hospital with primary infected
aortic aneurysms. To evaluate the pathogen-related differ-
ence, two patients with negative cultures were excluded. Of
the remaining 46 patients, 35 were men and 11 were
women, with a median age of 70.5 years (range, 35-90
years) at admission.
Medical comorbid conditions included diabetes melli-
tus in 10 patients, chronic obstructive lung disease in 4
patients, history of stroke in 9 patients, coronary artery
disease in 5 patients, chronic liver disease in 3 patients,
chronic renal disease with hemodialysis in 2 patients, idio-
pathic thrombocytopenic purpura in 2 patients, and pure
red blood cell dysplasia, hepatocellular carcinoma, bladder
cancer, hydrocephalus, iatrogenic Cushing syndrome, and
Evan syndrome in 1 patient each. Four patients had immu-
nodeficiency from steroid use.
Preoperative management. Clinically, infected aortic
aneurysms were often preceded by infection of the aorta.
Infected aorta was diagnosed from clinical evidence of
infection (fever, leukocytosis) and periaortic soft tissue
infiltration demonstrated at either computed tomogra-
phy19 or magnetic resonance imaging.20 Infected aortic
aneurysm was defined as aortic dilatation with diameter
more than 3 cm.18 Aneurysm location was classified as
suprarenal or infrarenal.
Intravenous antibiotic therapy was given after the diag-
nosis of infected aorta was confirmed. Salmonella species
infection was treated with intravenous ceftriaxone, 1000 to
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treated with antibiotic therapy, on the basis of culture
results and sensitivity testing. In patients with a good
response to antibiotic treatment (no fever, declining white
blood cell [WBC] count), surgical intervention was consid-
ered after a complete course of antibiotic treatment for 4 to
6 weeks in the hospital and the infection was controlled.
Imaging studies were repeated if new symptoms (recurrent
fever, pain, shock) developed or after complete antibiotic
treatment. Early surgical intervention, which was defined as
operation before 4 to 6 weeks of antibiotic treatment, was
performed only in patients with uncontrolled infection
(persistent fever, septic shock) or evidence of impending
aortic rupture (severe pain, shock, large pseudoaneurysm
formation on imaging studies).
Surgical technique. The surgical techniques and
postoperative management were based on the standard
treatment of infected aortic aneurysm reported previous-
ly.18 Surgical management consisted of wide debridement
of necrotic tissue, copious irrigation with saline solution,
and in situ repair with a Dacron graft through either
thoracotomy, thoracoabdominal incision, or midline lapa-
rotomy. In patients with proximal descending thoracic
aneurysm immediately distal to the left subclavian artery,
cardiopulmonary bypass was accomplished through the
femoral artery and femoral vein. Proximal aortic anastomo-
sis was performed with deep hypothermic circulatory arrest.
In patients with distal thoracic and abdominal aneurysm,
aortic anastomosis was performed with a simple clamp-and-
sew method. In patients with suprarenal abdominal aneu-
rysm involving visceral arteries the visceral arteries were
reimplanted directly to the graft as an island pedicle.
Postoperative management. Antibiotic agents were
administered intravenously in the hospital for at least 6
weeks after the operation and until clinical and laboratory
parameters (fever, WBC count, C-reactive protein [CRP])
were normal. Antibiotic therapy was continued orally after
discharge, with duration determined by the surgeon. WBC
count and CRP concentration were determined regularly
to assess for reinfection. Some patients underwent either
computed tomography or magnetic resonance imaging
after the operation.
Data collection. Data on Salmonella infection; pa-
tient age and gender; aneurysm location and medical co-
morbid conditions; and operation status, surgical proce-
dure, and clinical outcome were collected retrospectively
from medical records. We attempted to ascertain whether
the complication was graft-related and whether the prob-
lem was a direct cause of death. Clinical events leading to
death were classified as hospital-related or aneurysm-re-
lated death. In-hospital mortality was defined as death from
any cause during hospitalization; aneurysm-related death
was defined as death related to an infected aneurysm or to
the surgery. Prosthetic graft infection was classified as early
infection (immediately after operation) or late infection
(after discharge from the hospital).
Statistical analysis. Comparison between groups was
performed with the 2 test, Fisher exact test, and Mann-Whitney U test. Stepwise logistic regression was used to
identify risk factors for hospital death and aneurysm-related
death. The actuarial survival curve was plotted with the
Kaplan-Meier method.
RESULTS
Patients. At presentation, all patients had a positive
blood or tissue culture, 89% were febrile, and 73% had
localized pain. Twenty infections were suprarenal (aortic
arch, n 2; proximal descending thoracic aortic aneurysm,
n  5; distal descending thoracic aortic aneurysm, n  6;
suprarenal abdominal aortic aneurysm, n  7) and 26
infections were infrarenal (infrarenal abdominal aortic an-
eurysm, n  25; iliac artery aneurysm, n  2).
At imaging, aortic saccular aneurysm was present in 37
patients (80%) and infected aorta or fusiform aneurysm in
nine patients. Among the 37 patients with saccular aneu-
rysms identified on the initial imaging study, 18 had im-
pending rupture of large saccular aneurysms (diameter,5
cm). Eleven of these patients underwent urgent operation
because of severe pain or shock, one received intravenous
antibiotic therapy for 4 days before operation, and six
declined operation because of advanced age and severe
medical conditions. The remaining 19 patients, with small
saccular aneurysms (diameter4 cm) and stable vital signs,
received intravenous antibiotic therapy before surgical in-
tervention.
Bacteriology. Cultures were obtained from blood or
tissue during operative debridement. The most common
responsible organism was Salmonella species in 35 patients
(76%), followed by S aureus in 3 patients (7%), Escherichia
coli in three patients (7%), Streptococcus species in 2 patients
(4%), Mycobacterium tuberculosis in 2 patients (4%), and
Bacteroides species in 1 patient. In 26 patients with infrare-
nal infections (85%) Salmonella species was the most com-
mon pathogenic microorganism.
Combined medical and surgical treatment. Surgery
was performed in 35 patients; 24 patients underwent elec-
tive operation and 11 patients underwent urgent operation.
In-hospital death occurred in 4 of 35 patients operated on.
The first hospital death was in a 78-year-old man who
underwent emergency operation to treat septic shock and
localized rupture of a suprarenal aneurysm infected with
Bacteroides species. He had early polymocrobial prosthetic
graft infection with Bacteroides thetaiotaomicron, Pseudo-
monas aeruginosa, and then methicillin-resistant S aureus.
He died of overwhelming sepsis 4 months after the opera-
tion. The second in-hospital death occurred in a 66-year-
old man who underwent emergency surgery to treat a
ruptured infrarenal aneurysm with Mycobacterium tubercu-
losis. Early prosthetic graft infection was complicated by an
aortoenteric fistula. The patient died of massive gastroin-
testinal bleeding 2 months after the operation. The third
hospital death occurred in an 86-year-old man who under-
went emergency surgery to treat a ruptured descending
thoracic aortic aneurysm infected with Salmonella species.
He had esophageal perforation, and died of overwhelming
sepsis with methicillin-resistant S aureus 2 months after the
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man who had a ruptured infrarenal aneurysm infected with
Salmonella species. He had early prosthetic graft infection,
and died of sepsis 1 month after the operation. All four
patients who died in hospital underwent urgent operation
before active infection could be controlled. The median
length of stay was 50 days (range, 2-161 days).
There was no perioperative intestinal ischemia or peri-
operative limb loss in the 31 surgical survivors. Acute renal
failure occurred in two patients with suprarenal infection.
Among the 31 surgical survivors, two patients were lost
to follow-up. Six patients died late after discharge, three
from suspected late prosthetic graft infection, two from
malignancy, and one from postoperative respiratory failure.
The incidence of late prosthetic graft infection was 10%
(3 of 29 patients). The first occurred in a 57-year-old
woman with proximal descending thoracic aortic infection,
who died of massive upper gastrointestinal bleeding 4
months after the operation. Prosthetic graft infection and
aortoenteric fistula were suspected. The second late graft
infection occurred in a 69-year-old man with infrarenal
abdominal aortic infection, who died of anastomotic rup-
ture 3 months after the operation. The third graft infection
was in a 61-year-old man with proximal descending tho-
racic aortic infection, who died of acute respiratory failure 3
months after the operation. Prosthetic graft infection and
aneurysm rupture were suspected clinically, without proof
on imaging studies. One 81-year-old woman died of respi-
ratory failure 4 months after surgery, because of a chroni-
cally debilitating condition. One patient died of hepatocel-
lular carcinoma 14 months after surgery, and one patient
died of prostate cancer 12 months after surgery.
Twenty-three patients remain alive with median fol-
low-up of 27 months (range, 4-66 months). Twenty-two
patients were followed up as outpatients for longer than 1
year. There have been no late aortic or graft infections at
more than 4 months after the operation.
Medical treatment alone. During the same period 11
patients with infected aortic aneurysms were not operated
on. Five patients were discharged after complete antibiotic
treatment. Two patients with infrarenal Salmonella species
infection and one patient with E coli infrarenal infection had
small aneurysms (3 cm), and received medical therapy
only; they survived to discharge. Two patients with Salmo-
nella species infection over the aortic arch declined surgery
because of high operative risk; they survived to discharge.
Six patients (age range, 77-88 years) declined surgery
because of comorbid medical disease; they died of aneu-
rysm rupture 1 to 17 days after diagnosis of the infected
aneurysm.
Two of the five survivors who received medical treat-
ment only were lost of follow-up; the other three patients
were alive at follow-up of 22, 22, and 53 months, respec-
tively.
Salmonella and non-Salmonella infection. Clinical fea-
tures and outcomes were compared for patients with and
without Salmonella infection (Table I). There was no dif-
ference in age, gender, diabetes mellitus, brain disease,chronic liver disease, chronic renal disease, hematologic
disease, suprarenal location, fever, local pain, saccular an-
eurysm, or operation. Salmonella-infected patients tended
to be younger at presentation. There was a lower incidence
of chronic lung disease, lower in-hospital mortality, and
lower aneurysm-related mortality in Salmonella-infected
patients.
Risk factor analysis. As a whole, in-hospital death
occurred in 10 patients. Four of 35 patients who received
combined surgical and medical treatment died of early
prosthetic graft infection, and six of 10 patients who re-
ceived medical treatment only died of aneurysm rupture.
Aneurysm-related death occurred in 14 patients: 10 died in
hospital, 3 died of late prosthetic graft infection, and 1 died
of postoperative respiratory failure.
Overall, 30-day, 90-day, and 1-year mortality rates
were 3%, 12%, and 25%, respectively, in patients operated
on, and 45%, 59%, and 59%, respectively in patients not
operated on. Of 35 patients who underwent surgery, 30-
day mortality rates were 0% for elective operation and 9%
for non-elective operation (P  .314, Fisher exact test),
and 90-day mortality rates were 0% for elective operation
and 36% for non-elective operation (P .006, Fisher exact
test).
For all 46 patients, logistic regression model showed
that Salmonella species infection (odds ratio [OR], 0.07; P
 .032) and surgery (OR, 0.06; P  .009) were negative
predictors of 90-day mortality. Advanced age (OR, 1.08; P
 .033) was a positive predictor of 1-year mortality, and
Salmonella species infection (OR, 0.17; P  .055) was a
possible negative predictor of 1-year mortality.
For 35 patients operated on, logistic regression analysis
showed that urgent surgery was a positive predictor of
90-day mortality (OR, 6.78; P  .001) and 1-year mortal-
ity (OR, 5.83; P  .044). Multivariate logistic regression
Table I. Comparison of Salmonella vs non-Salmonella
infected aortic aneurysms
Variable
Salmonella
(n  35)
Non-
Salmonella
(n  11) P
n % n %
Male gender 29 83 6 56 .100
Age (y) (mean  SD) 67.7  12.7 75.7  11.0 .0598
Diabetes mellitus 9 26 1 9 .410
Chronic lung disease 1 3 3 27 .037*
History of stroke 6 17 3 27 .664
Chronic liver disease 3 9 0 0 .999
Chronic renal disease 2 6 0 0 .999
Hematologic disease 3 9 1 9 .999
Suprarenal location 13 37 7 64 .169
Fever 31 89 10 91 .999
Local pain 25 71 9 82 .701
Saccular aneurysm 27 77 10 91 .421
Operation 27 77 8 73 .709
In-hospital death 4 11 6 55 .006*
Aneurysm-related death 7 20 7 64 .010*
*P  .05.
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of aneurysm-related death and Salmonella species infection
was a negative predictor (Table II).
DISCUSSION
Primary infected aortic aneurysms are rare and difficult
to treat. Most patients with infected aneurysms were im-
munocompromised hosts. The affected aortic segments
were usually heavily atherosclerotic. The most common
responsible organism for infected aorta in previous studies
was S aureus and Streptococcus species, followed by Salmo-
nella organisms.1-8,10-13 Infected aortic aneurysms have an
aggressive presentation and a complicated early outcome.
Management of infected aortic aneurysms remains one of
the most challenging clinical problems. Successful resolu-
tion of infected aortic aneurysms depends on early diagno-
sis, prolonged systemic antibiotic therapy, and timely sur-
gical intervention.1-18 Mortality is extremely high without
surgical intervention. There are substantial questions re-
garding the benefit of surgery, optimal surgical manage-
ment (in situ graft replacement vs extra-anatomic bypass),
duration of oral antibiotic therapy, and predictors of clinical
outcome (type of microorganism).
Surgery. Surgery included either in situ graft replace-
ment or extra-anatomic bypass. In situ graft replacement
was traditionally considered contraindicated in patients
with severe purulent infection, S aureus infection, and
Salmonella species infection, because of the risk for early
graft infection.4,7-9 Therefore extra-anatomic bypass was
recommended in patients with infrarenal infection, and in
situ graft replacement in patients with suprarenal infec-
tion.4,7-9,15 However, extra-anatomic bypass is associated
with inferior patency and the necessity of future reconstruc-
tion. There was a high incidence of complications with
extra-anatomic bypass, including a 20% rate of stump dis-
ruption, a 20% to 29% rate of amputation, and a 20% risk for
reinfection.21 Increasingly, studies1-3,5 show that in situ
graft replacement is successful if infection is promptly con-
firmed, all possibly infected tissue is resected, and antibiotic
therapy is administered for a prolonged period. Whether in
situ graft replacement can be performed in every patient
with an infected aortic aneurysm remains unclear.
Salmonella species infection is common in Taiwan, and
was the most common responsible pathogen in our study
patients. Both infrarenal and suprarenal infections in our
patients were treated with wide debridement of infected
aorta, in situ graft replacement, and intravenous antibiotic
therapy for 4 to 6 weeks. During the same period we did
Table II. Predictors of aneurysm-related death*
Variable Odds ratio
Standard
error
Advanced age 1.091734 0.0402452
Salmonella 0.1962316 0.1625003
*Multivariate logistic regression analysis.not treat primary infected aortic aneurysms with extra-
anatomic bypass. The in-hospital mortality rate was 55% in
our patients who received medical treatment alone, and
11% in our patients who received combined medical and
surgical treatment. Five patients, four with Salmonella spe-
cies infection and one with E coli infection, survived to
discharge without surgical intervention. This was in con-
trast to a dismal prognosis of medically treated patients in
previous reports.15 It was attributed to careful surveillance
and advancement in antibiotic treatment in recent decades.
Aneurysm rupture was the main cause of death in our
patients who received medical treatment alone, and early
prosthetic graft infection and sepsis was the most common
cause of in-hospital death in our patients who received
combined medical and surgical treatment. All four in-
hospital deaths and three of six late deaths were attributed
to continued infection due to sepsis or graft infection.
These patients underwent urgent surgery because of shock
or large saccular aneurysms. In 24 patients who underwent
elective surgery there was no aneurysm-related death. With
surgical intervention and prolonged intravenous antibiotic
therapy, in situ graft replacement provided excellent results
in carefully selected patients who underwent elective oper-
ation. However, mortality was still high in patients under-
going urgent operation. We recommend in situ graft re-
placement only in patients with controlled infection, and
elective operation.
Predictors of death. Oderich et al,5 with 43 patients
with infected aortic aneurysm, reported that the primary
determinants of aneurym-related death were extensive peri-
aortic infection, female gender, S aureus infection, aneu-
rysm rupture, and suprarenal aneurysm location. Sessa et
al,13 with 18 patients with infrarenal infections, reported
poor prognostic factors of aneurysm rupture and Salmo-
nella species infection. Most previous reports of infected
aortic aneurysms described fewer than a dozen patients.
Because of the small number of study patients, it is not
possible to demonstrate statistically significant risk factors
for aneurysm-related death. The current report of 46 in-
fected patients is among the largest. In our study, indepen-
dent predictors of aneurysm-related death at multivariate
analysis were advanced age, non-Salmonella infection, and
no surgery. Type of aneurysm, saccular or fusiform, was not
a predictor of mortality. Urgent operation was a positive
predictor of 90-day mortality. Surgery was recommended
because of its benefit in patients with infected aortic
aneurysms.
z P  z 95% Confidence interval
.38 .017 1.015637 1.173532
.97 .049 0.0387155 0.9946098
2
1
ing to
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found in about 35% of all infected aortic aneurysms.4
Previous studies reported that hospital survival was poor in
patients with Salmonella species infection.13-16 Salmonella
is thought by many to exhibit a more virulent course
because of its ability to invade the normal intima and cause
early aneurysm rupture. In addition to aneurysm rupture,
Salmonella infection greatly increases the risk for prosthetic
graft infection after in situ graft replacement.13
Soravia-Dunand et al15 reviewed 140 definite and
probable cases with Salmonella infection from the litera-
ture, and reported an in-hospital mortality rate of 40% in
patients who received combined medical and surgical inter-
ventions, and 96% in patients who received antibiotic ther-
apy alone. The survival rate was 71% after extra-anatomic
bypass, and 51% after in situ graft replacement. Veraldi et
al22 reported a reinfection rate of 30% in Salmonella-in-
fected patients who survived surgery. We have reported a
high incidence of endovascular infection in patients with
non-typhoid salmonellosis bacteremia,23 and an excellent
outcome in patients with Salmonella-infected aortic aneu-
rysms.18 Here we prove that patients with Salmonella-
infected aortic aneurysms had a better outcome than pa-
tients with non-Salmonella-infected aortic aneurysms.
Duration of oral antibiotic therapy. The required
duration of oral antibiotic therapy after discharge is not well
established; recommendations range from 6 to 8 weeks to
lifelong.1-18,24 In our opinion, postoperative antibiotic
therapy should be administered for at least 4 months after
the operation, and should be discontinued only when care-
ful examination reveals no further signs of infection (fever,
Actuarial survival accordleukocytosis, high serum titer of CRP). Although pros-
thetic graft infections have been reported up to 2 years after
surgery,5 no patients in our study had graft infection 4
months after the operation. As shown in the Fig, the
survival curve for our patients became flat 4 months after
treatment. We recommend that patients who demonstrate
a satisfactory clinical response to intravenous antibiotic
treatment during the perioperative period do not require
lifelong antibiotic therapy.
Study limitations. The major limitations of our study
are that it was a retrospective study with a small number of
patients. However, this is the first study, and among the
largest series, to analyze risk factors for death in patients
with primary infected aortic aneurysms. With such limita-
tions, we attempted to identify variables associated with
poor prognosis. Age and Salmonella infection were the
variables most significantly associated with in-hospital and
aneurysm-related death. Further multi-institutional studies
may provide more information about optimal treatment
strategy and prognostic factors.
In conclusion, with timely surgical intervention and
prolonged antibiotic treatment, in situ graft replacement
provides an excellent outcome in patients with primary
infected aortic aneurysms who undergo elective surgery.
Mortality is still high in patients undergoing urgent sur-
gery. Advanced age, non-Salmonella infection, and no op-
eration were major determinants of mortality.
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